BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21177701)

  • 21. Contribution of the 5-HT(1B) receptor to hypoxia-induced pulmonary hypertension: converging evidence using 5-HT(1B)-receptor knockout mice and the 5-HT(1B/1D)-receptor antagonist GR127935.
    Keegan A; Morecroft I; Smillie D; Hicks MN; MacLean MR
    Circ Res; 2001 Dec; 89(12):1231-9. PubMed ID: 11739290
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Altered gene expression in pulmonary tissue of tryptophan hydroxylase-1 knockout mice: implications for pulmonary arterial hypertension.
    Rothman RB; Cadet JL; Dersch CM; McCoy MT; Lehrmann E; Becker KG; Bader M; Alenina N; Baumann MH
    PLoS One; 2011 Mar; 6(3):e17735. PubMed ID: 21464983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Serotonin and Pulmonary Hypertension; Sex and Drugs and ROCK and Rho.
    MacLean MR; Fanburg B; Hill N; Lazarus HM; Pack TF; Palacios M; Penumatsa KC; Wring SA
    Compr Physiol; 2022 Aug; 12(4):4103-4118. PubMed ID: 36036567
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Fluoxetine attenuates chronic methamphetamine-induced pulmonary arterial remodelling: possible involvement of serotonin transporter and serotonin 1B receptor.
    Liu M; Wang Y; Wang HM; Bai Y; Zhang XH; Sun YX; Wang HL
    Basic Clin Pharmacol Toxicol; 2013 Feb; 112(2):77-82. PubMed ID: 22900600
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Imatinib attenuates hypoxia-induced pulmonary arterial hypertension pathology via reduction in 5-hydroxytryptamine through inhibition of tryptophan hydroxylase 1 expression.
    Ciuclan L; Hussey MJ; Burton V; Good R; Duggan N; Beach S; Jones P; Fox R; Clay I; Bonneau O; Konstantinova I; Pearce A; Rowlands DJ; Jarai G; Westwick J; MacLean MR; Thomas M
    Am J Respir Crit Care Med; 2013 Jan; 187(1):78-89. PubMed ID: 23087024
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transgenic mice overexpressing the 5-hydroxytryptamine transporter gene in smooth muscle develop pulmonary hypertension.
    Guignabert C; Izikki M; Tu LI; Li Z; Zadigue P; Barlier-Mur AM; Hanoun N; Rodman D; Hamon M; Adnot S; Eddahibi S
    Circ Res; 2006 May; 98(10):1323-30. PubMed ID: 16614302
    [TBL] [Abstract][Full Text] [Related]  

  • 27. P21-dependent protective effects of a carbon monoxide-releasing molecule-3 in pulmonary hypertension.
    Abid S; Houssaïni A; Mouraret N; Marcos E; Amsellem V; Wan F; Dubois-Randé JL; Derumeaux G; Boczkowski J; Motterlini R; Adnot S
    Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):304-12. PubMed ID: 24334871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Gene therapy by targeted adenovirus-mediated knockdown of pulmonary endothelial Tph1 attenuates hypoxia-induced pulmonary hypertension.
    Morecroft I; White K; Caruso P; Nilsen M; Loughlin L; Alba R; Reynolds PN; Danilov SM; Baker AH; Maclean MR
    Mol Ther; 2012 Aug; 20(8):1516-28. PubMed ID: 22525513
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Peroxisome proliferator-activated receptor-γ ameliorates pulmonary arterial hypertension by inhibiting 5-hydroxytryptamine 2B receptor.
    Liu Y; Tian XY; Mao G; Fang X; Fung ML; Shyy JY; Huang Y; Wang N
    Hypertension; 2012 Dec; 60(6):1471-8. PubMed ID: 23108648
    [TBL] [Abstract][Full Text] [Related]  

  • 30. 5-HT(1B) autoreceptor regulation of serotonin transporter activity in synaptosomes.
    Hagan CE; McDevitt RA; Liu Y; Furay AR; Neumaier JF
    Synapse; 2012 Dec; 66(12):1024-34. PubMed ID: 22961814
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 5-HT1B receptor modulation of the serotonin transporter in vivo: studies using KO mice.
    Montañez S; Munn JL; Owens WA; Horton RE; Daws LC
    Neurochem Int; 2014 Jul; 73():127-31. PubMed ID: 24246466
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Induction of serotonin transporter by hypoxia in pulmonary vascular smooth muscle cells. Relationship with the mitogenic action of serotonin.
    Eddahibi S; Fabre V; Boni C; Martres MP; Raffestin B; Hamon M; Adnot S
    Circ Res; 1999 Feb; 84(3):329-36. PubMed ID: 10024307
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The serotonin hypothesis of pulmonary hypertension revisited.
    Maclean MR; Dempsie Y
    Adv Exp Med Biol; 2010; 661():309-22. PubMed ID: 20204739
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Polymorphisms in the serotonin transporter protein (SERT) gene in patients with pulmonary arterial hypertension.
    Baloira A; Núñez M; Cifrian J; Vilariño C; Ojeda M; Valverde D
    Arch Bronconeumol; 2012 Mar; 48(3):77-80. PubMed ID: 22177971
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 4,4'-Methylenedianiline Alters Serotonergic Transport in a Novel, Sex-Specific Model of Pulmonary Arterial Hypertension in Rats.
    Carroll-Turpin M; Hebert V; Chotibut T; Wensler H; Krentzel D; Varner KJ; Burn BR; Chen YF; Abreo F; Dugas TR
    Toxicol Sci; 2015 Sep; 147(1):235-45. PubMed ID: 26116029
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tryptophan hydroxylase 1 knockout and tryptophan hydroxylase 2 polymorphism: effects on hypoxic pulmonary hypertension in mice.
    Izikki M; Hanoun N; Marcos E; Savale L; Barlier-Mur AM; Saurini F; Eddahibi S; Hamon M; Adnot S
    Am J Physiol Lung Cell Mol Physiol; 2007 Oct; 293(4):L1045-52. PubMed ID: 17675372
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serotonin increases susceptibility to pulmonary hypertension in BMPR2-deficient mice.
    Long L; MacLean MR; Jeffery TK; Morecroft I; Yang X; Rudarakanchana N; Southwood M; James V; Trembath RC; Morrell NW
    Circ Res; 2006 Mar; 98(6):818-27. PubMed ID: 16497988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Attenuated methamphetamine-induced locomotor sensitization in serotonin transporter knockout mice is restored by serotonin 1B receptor antagonist treatment.
    Igari M; Shen HW; Hagino Y; Fukushima S; Kasahara Y; Lesch KP; Murphy DL; Hall FS; Uhl GR; Ikeda K; Yaegashi N; Sora I
    Behav Pharmacol; 2015 Feb; 26(1-2):167-79. PubMed ID: 25485646
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Continuous fluoxetine administration prevents recurrence of pulmonary arterial hypertension and prolongs survival in rats.
    Zhu SP; Mao ZF; Huang J; Wang JY
    Clin Exp Pharmacol Physiol; 2009 Aug; 36(8):e1-5. PubMed ID: 19473340
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Sex affects bone morphogenetic protein type II receptor signaling in pulmonary artery smooth muscle cells.
    Mair KM; Yang XD; Long L; White K; Wallace E; Ewart MA; Docherty CK; Morrell NW; MacLean MR
    Am J Respir Crit Care Med; 2015 Mar; 191(6):693-703. PubMed ID: 25608111
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.